Mahendra S. Ashawat
Kangar, HP, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
TYK2 signaling as a molecular bridge between cytokine storm and chronic inflammation: therapeutic implications of deucravacitinib.
Journal: Molecular biology reports
Published: June 11, 2026
Quality by Design-Guided Transethosomal Gel of Donepezil Hydrochloride and Quercetin for Potential Alzheimer's Management: Stability-Indicating Eco-Compatible RP-HPLC Method.
Journal: Drug development research
Published: June 01, 2026
From glycemic control to neuroprotection: alogliptin as a repurposed candidate for Huntington's disease.
Journal: Metabolic brain disease
Published: April 25, 2026
Precision RNA-based Gene Silencing and Theranostics Delivery Strategies for Glioma: Advances in siRNA and Emerging miRNA Therapeutics.
Journal: MicroRNA (Shariqah, United Arab Emirates)
Published: March 16, 2026
α-Synuclein as a molecular link between Parkinson's disease and chronic kidney disease: insights into the kidney-brain axis.
Journal: Metabolic brain disease
Published: March 13, 2026
Acitretin shows promising potential in Alzheimer's disease: retinoid-driven modulation of amyloid processing, neuroinflammation, and translational prospects.
Journal: Inflammopharmacology
Published: February 22, 2026
LLPS Inflammasome Metabo-Proteostatic Failure Axis in AD: Mechanistic and Translational Insights.
Journal: Molecular neurobiology
Published: January 26, 2026
Neuroinflammatory control of metabolism in huntington's disease: central role of P2 × 7 receptor mediated redox lipid/epigenetic crosstalk.
Journal: Inflammopharmacology
Published: December 18, 2025
Auranofin reimagined: an emerging therapeutic candidate for neurodegenerative diseases through molecular mechanistic insights.
Journal: Inflammopharmacology
Published: November 18, 2025
Sovateltide at the heart-brain axis crosstalk in Alzheimer's disease: a promising multi-target and cutting-edge therapeutic approach.
Journal: Inflammopharmacology
Published: November 04, 2025
Last Updated: 09/26/2026